Journal of Hepato-biliary-pancreatic Sciences · Nov 16, 2026
Current Status and Future Perspectives of Chemically Induced Liver Progenitor ( CLiP ) Research: Potential Applications in Liver Regenerative Medicine
By Eguchi S, Hamada T, Hara T et al.
Although liver transplantation is an established curative treatment for liver failure, it remains limited by donor shortages, surgical invasiveness, and complications related to immunosuppression. Hepatocyte transplantation has emerged as a less invasive alternative; however, its clinical application is constrained by the limited proliferative capacity of mature hepatocytes and the scarcity of donor cells. Recently, chemically induced liver progenitors (CLiPs) have been developed by reprogramming mature hepatocytes with small‐molecule compounds into progenitor‐like cells possessing high proliferative capacity and bipotent differentiation potential toward both hepatocytic and biliary lineages. Compared with induced pluripotent stem cells (iPSCs), CLiPs may offer advantages including lower tumorigenic risk, rapid generation, and preservation of mature hepatic functions. These characteristics make CLiPs promising candidates for liver regenerative medicine, disease modeling, drug screening, hepatocyte transplantation, and biliary regeneration. Advances in hepatocyte plasticity research have further provided the theoretical basis for CLiP technology. This review summarizes the history of liver regeneration research, hepatocyte plasticity, methods for CLiP establishment, and the molecular basis underlying CLiP induction and differentiation. We also discuss applications in transplantation and biliary regeneration, as well as current challenges in safety and regulatory science.
doi.org/10.1002/jhbp.70208Open accessPubMed 43037247Interventions